active ingredients:sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, fructose;
100 ml contain: sodium chloride-0.8 g; potassium chloride-0.0298 g calcium chloride dihydrate-0.0242 g magnesium chloride hexahydrate-0.0254 g fructose-10 g;
ion composition per 1000 ml: Na+- 136.89 mmol; to+- 4 mmol; Sa++- 1.65 mmol;
Mg++- 1,25 mmol; Cl- 146,69 mmol;
other ingredients:water for injection.The
Solution for infusion.
Basic physical and chemical properties:clear, colorless or slightly yellowish liquid theoretical osmolarity - 845 mOsm/l; pH of 3.0 - 6.0.The
Solutions for correction of violations of electrolyte balance. Electrolytes with carbohydrates. Code ATH B05V B02.The
Plasma-isotonic salt solution containing balanced structure of ions necessary for an organism and fructose. The drug compensates for the loss of liquid, electrolytes and partially - energy, restores water-salt balance. Fructose stimulates the formation of glucose and glycogen in the liver, improves the flow of glucose into cells. The metabolism of fructose is carried out independently of insulin, when it is used, the blood glucose level does not increase, which is important in the treatment of diabetics. Fructose exhibits a pronounced antiketogenic effect, has a slight diuretic effect, has a specific effect on protein metabolism, which manifests itself in the conservation of amino acids due to their less use in gluconeogenesis.
as a means to partial parenteral nutrition in ISO - and hypotonic dehydration due to uncontrollable vomiting, profuse diarrhea, intestinal obstruction, acute massive blood loss, burns, shock, collapse; to compensate for the requirements of carbohydrates, including diabetes and other infringements of recycling of glucose, under condition of normal acid-base balance of blood or it shifts to the alkaline side.
Edema, fluid overload, hypersensitivity to fructose and/or other components of the drug, intoxication with methanol, hyperlactatemia, hypertonic dehydration, metabolic acidosis.The
the Preparation should not be mixed with phosphate - and carbonate-containing solutions.
use with caution in cases of renal and/or hepatic insufficiency. Treatment is carried out under the control of water balance.
Because each 100 ml contains 10 g of fructose, to apply caution in patients with diabetes mellitus.
Prolonged use (more than 5 days) Glicosteril F10 is impractical, because this may be the cause of fructose-induced hyperglycemia and hypertriglyceridemia due to impaired lipid metabolism and reducing the number of glucose transporters on the outer surfaces of cell membranes.
the Drug should be used during pregnancy and lactation only for life indications in cases where the expected benefit of treatment for the mother exceeds the possible risk to the fetus/child.The
Data are not available due to the use of the drug exclusively in hospital.
Assign an adult intravenously.
intravenously drip At a rate of 2.5 ml/kg/h, that is, 180 ml/h with a body weight of 70 kg.the Maximum dose - 15 ml/kg/day (1.5 g fructose/kg/day), but not more than 1000 ml/day. The maximum speed of infusion-5 ml/kg/h, that is 350 ml/h with a body weight of 70 kg.
To quickly retrieve the target of the catalytic concentration of fructose is necessary to hold the jet infusion 50-60 ml Glicosteril F10.
Support the target concentration achieved by infusion of fructose Glicosteril F10 from 65 to 75 ml/hour for 12-24 hours.
For preparation of patients before operations urgent indicators glicosteril f 10 up to apply at a dose of 800-1200 ml in combination with colloid and crystalloid solutions.
In the preoperative period for patients scheduled on the eve of large surgical operations in various fields of surgery (abdominal, thoracic, cardiac surgery, orthopedics and traumatology, Oncology, neurosurgery) for the prevention of insulin resistance and hyperglycemia to enter intravenous drip 400 ml Glicosteril F10.The
do not use in Pediatrics due to lack of clinical trials.
if you exceed the recommended speed of administration may develop tachycardia, increased blood pressure, shortness of breath, headache, chest pain, abdominal pain. These symptoms quickly disappear on their own after the termination or a significant reduction in the rate of administration of the solution.
from the immune system:allergic reactions including skin and systemic manifestations, hyperthermia.
on the part of the cardiovascular system:fluctuations in blood pressure, swelling, tachycardia.
Violation vodno-elektrolitnogo balance:when holding a massive infusion therapy may experience metabolic electrolytes (potassium, calcium, sodium, chloride), lactic acidosis, gipergidratace.The
Keep at temperature not exceeding 25 ° C, inaccessible for children place.The
Drug should not be mixed with phosphate - and carbonate-containing solutions.The
200 ml or 250 ml, or 400 ml, or 500 ml in bottles.The
According to the recipe.The
closed joint-stock company "Infusion", Ukraine.
the City of Vinnitsa, St. Ivanova, D. 55.The
closed joint-stock company "Infusion", Ukraine.
Kiev, Moscow Avenue, d. 21-A.
heparin-INDAR injection solution 5000 IU/ml vial 5 ml (25000 IU) No. 5 has a local antithrombotic, anti-exudative and anti-inflammatory effect. The drug activates tissue metabolism, improves microcirculation, relieves swelling of tissues.
Medicine used in the treatment of:
Heparin, which is part of the drug, reduces the size of the blood clot and suspends the increase in blood clots. As a result of treatment with the drug, the risk of thrombosis and pulmonary embolism decreases, hematomas and blood clots dissolve.
the Product is prescribed in the form of intravenous or subcutaneous injections. To avoid the formation of hematoma every time you need to alternate the injection site. The first injection is used 1-2 hours before surgery. In the postoperative period, the drug should be administered to prevent the formation of hematomas and blood clots from 7 to 10 days.
with moderate to mild thrombosis administered intravenously on the first day of treatment for 10,000 IU of the drug every 4 hours. In severe stages, embolism and thrombosis are used intravenously at a dosage of 20,000 IU to 4 times a day.